Cloning and characterization of BAI2 and BAI3, novel genes homologous to brain-specific angiogenesis inhibitor 1 (BAI1)

Cytogenetics and Cell Genetics

Volumn 79, Issue 1-2, 1997, Pages 103-108

  Shiratsuchi, T ^a,c   Nishimori, H ^a   Ichise, H ^b   Nakamura, Y ^a   Tokino, T ^a  

^a Human Genome Center   (United States)

^b THE UNIVERSITY OF TOKYO   (Japan)

^c OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; COMPLEMENTARY DNA; PROTEIN P53;

ARTICLE; CHROMOSOME 1P; CHROMOSOME 6Q; CHROMOSOME 8Q; CONTROLLED STUDY; GENE EXPRESSION; GENE MAPPING; GENETIC ANALYSIS; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR CLONING; MULTIGENE FAMILY; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ASTROCYTES; BRAIN NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 6; CLONING, MOLECULAR; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; NEOVASCULARIZATION, PATHOLOGIC; NERVE TISSUE PROTEINS; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84920321315     PISSN: 03010171     EISSN: 1424859X     Source Type: Journal    
DOI: 10.1159/000134693     Document Type: Article

References (27)

1. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local alignment search tool. J molec Biol 215:403-410 (1990).
2. Baud V, Chissoe ST, Viegas-Pequignot E, Diriong S, N’Guyen VC, Roe BA, Lipinski M: EMR1, an unusual member in the family of hormone receptors with seven transmembrane segments. Genomics 26:334-344 (1995).
3. Bomstein P: Thrombospondins: structure and regulation of expression. FASEBJ 6:3290-3299 (1992).
4. d'Souza SE, Ginsberg MH, Plow EF: Arginvl-glycyl-aspartic acid (RGD): a cell adhesion motif. Trends BiochemSci 16:246-250 (1991).
5. Fidler IJ, Ellis LM: The implications of angiogenesis for the biology and therapv of cancer metastasis Cell 79:185-188 (1994).
6. Folkman J: What is the evidence that tumors are angiogenesis dependent? J nail Cancer Inst 82:4-6 (1989).
7. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1:27-31 (1995).
8. Good EJ, Polverini PJ, Rastinejad F, Le Beau MM, Lemons RS, Frazier WA, Bouck NP: A tumor suppressor-dependent inhibitor of angiogenesis is im-munologically and functionally indistinguishable from a fragment of thrombospondin. Proc natl Acad Sci. USA 87:6624-6628 (1990).
9. Haas TA, Plow EF: integrin-ligand interactions: a year in review. Curr Biol 6:656-662 (1994).
10. Hamann J, Eichler W, Hamann D, Kerstcrns HMJ, Poddighe PJ, Hoovers JMN, Hartmann E, Strauss M, van tier RAW: Expression cloning and chromosomal mappingof the leukocyte activation antigen CD97. a new seven-span transmembrane molecule of the secretin receptor superfamilv with an unusual extracellular domain. J Immunol 155: 1942-1950 (1995).
11. Han H-J, Maruyama M, Baba S, Park JG, Nakamura Y: Genomic structure of human mismatch repair gene. hMLH 1. and its mutation analysis in patients with hereditary non-polyposis colorectal cancer (HNPCC). Hum mol Genet 4:237-242 (1995).
12. Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigene-sis. Cell 86:353-364 (1996).
13. Hori A, Sasada R, Matsutani E, Naito K, Sakura Y, Fujita T, Kozai Y: Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor. Cancer Res 51:6180-6184 (1991).
14. Inazawa J, Saito H, Ariyama T, Abe T, Nakamura Y: High-resolution cytogenetic mapping of 342 new cosmid markers including 43 RFI.P markers on human chromosome 17 by fluorescence in situ hybridization. Genomics 17:153-162 (1993).
15. Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW, Vogelstein B: Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256:827-830 (1992).
16. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N: Inhibitor of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362:841-844 (1993).
17. Kyte J, Doolittle RF: A simple method for displaying the hydropathic character of a protein. J mol Biol 157:105-132 (1982).
18. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A: Glioblastoma growth inhibited in vivo by a dominant-negativeFlk-I mutant. Nature 367:576-579 (1994).
19. Nishimori H, Shiratsuchi T, Urano T, Kimura Y, Kiyono K, Tatsumi K, Yoshida S, Ono M, Kuwano K, Nakamura Y, Tokino T: A novel brain-specific p53-target gene, BAIl. containing thrombospondin tvpel repeats inhibits experimental angiogenesis. Oncogene (in press 1997).
20. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J: Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by Lewis lung carcinoma. Cell 79:315-328 (1994).
21. Parangi S, O'Reilly M, Christofori G, Holmgren L, Grosleld J, Folkman J, Hanahan D: Antiangiogen-ic therapy of transgenic mice impairs de novo tumor growth. Proc natl Acad Sci. USA 93:2002-2007 (1996).
22. Rastinejad F, Polverini PJ, Bouck NP: Regulation of the activity of an inhibitor of angiogenesis by a cancer suppressor gene. Cell 56:345-355 (1989).
23. Ren R, Mayer BJ, Cicchetti P, Baltimore D: Identification of a ten-amino acid proline-rich SH3 binding site. Science 259:1157-1161 (1993).
24. Tokino T, Thiagalingam S, El-Deiry WS, Waldman T, Kinzler KW, Vogelstein, B: p53 tagged sites from human genomic DNA. Hum Mol Genet 3:1537-1542 (1994).
25. Tolsma SS, Volpert OV, Good DJ, Frazier WA, Polverini PJ, Bouck N: Peptides derived from two separate domains of the matrix protein thrombospon-din-l have anti-angiogenetic activity. J Cell Biol 122:497-511 (1993).
26. van Meir EG, Polverini PJ, Chazin VR, Su HH-J, de Tribdet N, Cavcnee WK: Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nature Genet 8:171-176 (1994).
27. Vogelstein B, Kinzlcr KW: p53 function and dysfunction. Cell 70:523-526 (1992).